Bank of Montreal
PRME icon

Bank of Montreal’s Prime Medicine PRME Stock Holding History

Bank of Montreal’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-46,637
Closed -$327K – 4165
2024
Q1 		$327K Buy
46,637
+1,637
+4% +$12.4K ﹤0.01% 2725
2023
Q4 		$430K Buy
+45,000
New +$347K ﹤0.01% 2611

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

Bank of Montreal's PRME Position: Q2 2024 in Review

Bank of Montreal sold out of Prime Medicine (PRME) in Q2 2024, closing a stake of 46,637 shares — an estimated $327K sold.

Bank of Montreal first reported a position in PRME in Q4 2023 and held it in 2 quarters. The position peaked at $430K in Q4 2023. 122 funds tracked by Wall St. Rank hold PRME as of Q2 2024.

  • Bank of Montreal reported no remaining Prime Medicine position as of Q2 2024 after selling out during the quarter.
  • Bank of Montreal sold 46,637 Prime Medicine shares in Q2 2024, an estimated $327K.
  • Bank of Montreal first reported a position in Prime Medicine in Q4 2023 and held it in 2 quarters.
  • Bank of Montreal's Prime Medicine position peaked at $430K in Q4 2023.
  • 122 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2024.

Based on Bank of Montreal's 13F filing for Q2 2024, filed 14 Aug 2024.